This is the first study on how a substance with anti-progestogenic activity affects amphibian reproduction. Mifepristone, a synthetic anti-progestin used in abortion pills, was chosen as model compound. African clawed frog (Xenopus laevis) females were exposed to four mifepristone concentrations (0.7, 9, 120, and 1380ng∙L−1) for 30 days. A control group was also included. Egg-laying during the experiment was significantly less at the highest concentration. At the experiment’s end, mifepristone-exposed and control females were randomly mated with sexually mature males. Breeding rate for females exposed to 1380ng∙L−1 mifepristone was only 50%. Histology revealed no significant changes in gonads, thyroid, or liver. Females exposed to 1380ng∙L−1 mifepristone had lower estradiol levels in plasma, lower mRNA expression of lh and fsh in brain–pituitary complex, and p450scc in ovaries. In liver, mRNA level of npr was significantly increased in females exposed to 120ng∙L−1 mifepristone. mRNA expression of mpr, erβ, dio2, and dio3 were upregulated in animals exposed to 9ng∙L−1 and 120ng∙L−1 mifepristone, whereas vtg expression was significantly downregulated in females exposed to 1380ng∙L−1 mifepristone. All these findings show that exposure to compounds with anti-progestogenic activity affects the hypothalamus–pituitary–gonad axis and decreases reproductive success.
Read full abstract